Nevin Alayvaz Aslan

Akademik Profiller

1. 1
   Long-Term Safety and Efficacy of Imatinib in Chronic Myeloid Leukemia: Real-World Evidence from a Single-Center StudySakarya Medical Journal
   2025
2. 2
   Daratumumab enhances the overall response to multiple myeloma therapy as the number of cycles increasesPamukkale Medical Journal
   2024
3. 3
   Adult acute megakaryoblastic leukemia with persistent diarrhea and extreme thrombocytosis: A very unusual caseIndian Journal of Pathology and Microbiology
   2024
4. 4
   GDF11 level and its effect on prognosis in patients with acute myeloid leukemiaJournal of Investigative Medicine
   2024
5. 5
   Incidence of and risk factors for venous thrombosis in hospitalized patients with hematologic malignancies: A single-center, prospective cohort studyNorthern Clinics of Istanbul
   2024
6. 6
   Bosutinib-induced massive pleural effusion: Cross-intolerance with all tyrosine kinase inhibitorsJournal of Oncology Pharmacy Practice
   2023
7. 7
   The Effect of Culture Positivity on Treatment Response and Survival in Patients with Acute Myeloid Leukemia; Single Center Data, Retrospective AnalysisLLM Dergi
   2022
8. 8
   Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experienceAnnals of Hematology
   2020
9. 9
   Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor - A Multicenter Cohort StudyThe Turkish Journal of Hematology
   2020
10. 10
    A multi-center study on the efficacy of eltrombopag in management of refractory chronic immune thrombocytopenia: A real-life experience,Refrakter kronik immün trombositopeni tedavisinde eltrombopagın etkinliğine ilişkin çok merkezli bir çalışma: Gerçek yaşam deneyimiTurkish Journal of Hematology
    2019

Yayın listesi ORCID kaydından alındı.